Finally, RRM2 has been found to be correlated with the malignant phenotypes of prostate cancer, and bioinformatic analysis suggested that RRM2 may have impacts on tumor microenvironment reconstruction and enzalutamide resistance. This evidence concerns the gene RRM2 and prostate carcinoma.